Difference between revisions of "Part:BBa K1932001"
Line 5: | Line 5: | ||
Part BBa_K1932001was originally cloned from the plasmid of Bifidobacterium that contains two orf sequences.(The plasmid had a G + C content of 62.0%, and contained two open reading frames, orf1 and orf2).This sequence is essential for the shuttling of the plasmid from E.<i>coli</i> to Bifidobacterium. | Part BBa_K1932001was originally cloned from the plasmid of Bifidobacterium that contains two orf sequences.(The plasmid had a G + C content of 62.0%, and contained two open reading frames, orf1 and orf2).This sequence is essential for the shuttling of the plasmid from E.<i>coli</i> to Bifidobacterium. | ||
− | Characterization: | + | <p style="font-size:130%">'''Characterization:'''</p> |
The part of BBa_K1932001 was synthesized and cloned into a pGH vector by Generay Biotechnology. This plasmid was cut with the restriction enzyme, EcoRⅠand PstⅠ, and separated by 1% agarose gel (Fig.1). | The part of BBa_K1932001 was synthesized and cloned into a pGH vector by Generay Biotechnology. This plasmid was cut with the restriction enzyme, EcoRⅠand PstⅠ, and separated by 1% agarose gel (Fig.1). | ||
+ | |||
+ | "https://static.igem.org/mediawiki/2016/d/da/T--Jilin_China--p1-1.png" | ||
+ | |||
+ | <p style="font-size:75%">'''Fig.1. (1): pGH+PMB1; (2) marker;3:pGH+PMB1 digested with EcoRⅠ and PSTⅠ'''</p> | ||
The sequence of PMB1 was ligated into the vector pSB1C3 by ligase in 16℃ overnight, and the ligated products were transformed into the E.<i>coli</i>(Fig.2). | The sequence of PMB1 was ligated into the vector pSB1C3 by ligase in 16℃ overnight, and the ligated products were transformed into the E.<i>coli</i>(Fig.2). | ||
− | + | "https://static.igem.org/mediawiki/2016/a/a3/T--Jilin_China--p1-2.png" | |
+ | |||
+ | <p style="font-size:75%">'''Fig.2. (1) control only DH5α; (2) DH5α transformed with BBa_K1932001 (the PMB1+pSB1C3 vector)'''</p> | ||
− | |||
− | The | + | The detailed protocols of these experiments were shown in table 1 and table 2. |
+ | The sequence of PMB1 differs from the sequence of pMB1 from the vector, pSB1C3,which was shown with the tool of BLAST online(Fig.3). | ||
− | + | <p style="font-size:130%">'''References:'''</p> | |
【1】Rossi, M., Brigidi, P., y Rodriguez, A. G. V., &Matteuzzi, D. (1996).Characterization of the plasmid pMB1 from Bifidobacterium <i>longum</i> and its use for shuttle vector construction.<i>Research in microbiology, 147(3)</i>, 133-143. | 【1】Rossi, M., Brigidi, P., y Rodriguez, A. G. V., &Matteuzzi, D. (1996).Characterization of the plasmid pMB1 from Bifidobacterium <i>longum</i> and its use for shuttle vector construction.<i>Research in microbiology, 147(3)</i>, 133-143. |
Revision as of 19:31, 19 October 2016
orf1 and orf2 from Bifidobacterium
Part BBa_K1932001was originally cloned from the plasmid of Bifidobacterium that contains two orf sequences.(The plasmid had a G + C content of 62.0%, and contained two open reading frames, orf1 and orf2).This sequence is essential for the shuttling of the plasmid from E.coli to Bifidobacterium.
Characterization:
The part of BBa_K1932001 was synthesized and cloned into a pGH vector by Generay Biotechnology. This plasmid was cut with the restriction enzyme, EcoRⅠand PstⅠ, and separated by 1% agarose gel (Fig.1).
""
Fig.1. (1): pGH+PMB1; (2) marker;3:pGH+PMB1 digested with EcoRⅠ and PSTⅠ
The sequence of PMB1 was ligated into the vector pSB1C3 by ligase in 16℃ overnight, and the ligated products were transformed into the E.coli(Fig.2).
""
Fig.2. (1) control only DH5α; (2) DH5α transformed with BBa_K1932001 (the PMB1+pSB1C3 vector)
The detailed protocols of these experiments were shown in table 1 and table 2.
The sequence of PMB1 differs from the sequence of pMB1 from the vector, pSB1C3,which was shown with the tool of BLAST online(Fig.3).
References:
【1】Rossi, M., Brigidi, P., y Rodriguez, A. G. V., &Matteuzzi, D. (1996).Characterization of the plasmid pMB1 from Bifidobacterium longum and its use for shuttle vector construction.Research in microbiology, 147(3), 133-143.
【2】Matteuzzi, D.,Brigidi, P., Rossi, M., & Di, D. (1990).Characterization and molecular cloning of Bifidobacterium longum cryptic plasmid pMB1.Letters in applied microbiology, 11(4), 220-223.
【3】Xu, Y. F., Zhu, L. P., Hu, B., Fu, G. F., Zhang, H. Y., Wang, J. J., &Xu, G. X. (2007). A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy.Cancer gene therapy, 14(2), 151-157.
【4】Corneau, N., Émond, É., &LaPointe, G. (2004).Molecular characterization of three plasmids from Bifidobacterium longum.Plasmid, 51(2), 87-100.
【5】Hu, B., Kou, L., Li, C., Zhu, L. P., Fan, Y. R., Wu, Z. W., ... &Xu, G. X. (2009). Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth. Cancer gene therapy, 16(8), 655-663.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI site found at 935